Evaluation of Candidate Biomarkers of Type 1 Diabetes via the Core for Assay Validation

Recognizing an increasing need for biomarkers that predict clinical outcomes in type 1 diabetes (T1D), JDRF, a major funding organization for T1D research, recently instituted the Core for Assay Validation (CAV) to accelerate the translation of promising assays from discovery to clinical implementat...

Full description

Bibliographic Details
Main Authors: Cate Speake, Jared M. Odegard
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Biomarker Insights
Online Access:https://doi.org/10.4137/BMI.S29697

Similar Items